Novartis is a pharmaceutical group based in Switzerland. Co. specializes in the research, development, manufacturing and marketing of healthcare products. Co.'s portfolio includes medicines, eyecare, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Co.'s operations are organized along five business divisions: Pharmaceuticals (patent-protected prescription medicines); Alcon (vision care products); Sandoz (generic parmaceuticals); Vaccines and Diagnostics (Human vaccines and blood-testing diagnostics); and Consumer Health (Over-the-counter medicines; veterinary products for farm and companion animals; and contact lenses and lens-care products).

View SEC Filings from NVS instead.
Filers who had this stock in their top 10: 19
13F Filers holding this stock: 838
Aggregate shares on 03/31/2016: 235,963,051
Aggregate shares on 12/31/2015: 232,535,431
Percent change: 1.47%
Funds creating new positions: 54
Funds Adding to an existing position: 319
Funds closing out their position: 97
Funds reducing their position: 338

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 03/31/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more